The adenoviral-vectored vaccines are made with the abortion-tainted HEK293 fetal cell lines.

A new experimental “adenoviral-vectored” trial COVID vaccine that can be inhaled rather than injected and was in part developed with abortion-tainted cell lines will soon enter phase two of human trials in Canada.

The inhaled trial version of the COVID “trivalent adenoviral-vectored” vaccine is made in Canada and developed at McMaster University in Hamilton, Ontario. The new vaccine was created with funding from the Canadian federal government.

As noted in a press release on Friday, Karen Mossman, McMaster’s vice president of research, said the new aerosol version of the COVID shot was developed due to a “pressing need to develop new, more effective next-generation vaccine strategies.”

https://www.lifesitenews.com/news/inhaled-version-of-covid-vaccine-set-to-enter-second-phase-of-human-trials-in-canada/?